American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility-Reference-Cited by-同舟云学术

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Published:2010-02-10 Issue:5 Volume:28 Page:893-901
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Robson Mark E.¹,Storm Courtney D.¹,Weitzel Jeffrey¹,Wollins Dana S.¹,Offit Kenneth¹

Affiliation:

1. From the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; and Department of Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.27.0660

Reference56 articles.

1. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

2. American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

3. Hereditary Cancer Predisposition Syndromes

4. Disparities in BRCA testing: when insurance coverage is not a barrier

Cited by 368 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry;The Breast;2024-12

2. Genomic testing for germline predisposition to hematologic malignancies;Blood Research;2024-03-08

3. Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention;JAMA Network Open;2024-02-14

4. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-02-10

5. Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community;Public Health Genomics;2024